Rexahn Pharmaceuticals

0 followers


Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.

Employees

11-50

Links

Org chart

Mina Sooch
Vice Chair of the Board & CEO

Mina Sooch

Collapse
Amy Rabourn
SVP of Finance
Charlie Hoffmann
SVP of Corporate Development
Ronil Patel
SVP of Operations & Business Development
Drey Coleman
VP of Clinical Operations
Barbara Withers
VP of Clinical & Regulatory Strategy
Daniela C. Oniciu
Global Head of R&D
Chris Ernst
Global Head QA & Manufacturing
Mitchell Brigell
Head of Clinical Development & Strategy
Bindu Manne
Head of Market Development & Commercialization
Laura Gambino
Director of Project Management
Mark R. Kelley
Scientific Advisor for APX Program